Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Salvatore, Lo Vullo"'
Autor:
Anna M. Frezza, Vinod Ravi, Salvatore Lo Vullo, Bruno Vincenzi, Francesco Tolomeo, Tom Wei‐Wu Chen, Pawel Teterycz, Giacomo G. Baldi, Antoine Italiano, Nicolas Penel, Antonella Brunello, Florance Duffaud, Nadia Hindi, Shintaro Iwata, Alannah Smrke, Alexander Fedenko, Hans Gelderblom, Winette Van Der Graaf, Aurore Vozy, Elizabeth Connolly, Massimiliano Grassi, Robert S. Benjamin, Javier‐Martin Broto, Giovanni Grignani, Robin L. Jones, Akira Kawai, Andrzej Tysarowski, Luigi Mariani, Paolo G. Casali, Silvia Stacchiotti
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2645-2659 (2021)
Abstract Background This observational, retrospective effort across Europe, US, Australia, and Asia aimed to assess the activity of systemic therapies in EHE, an ultra‐rare sarcoma, marked by WWTR1‐CAMTA1 or YAP1‐TFE3 fusions. Methods Twenty sa
Externí odkaz:
https://doaj.org/article/56e3c27fbb994c9fa4bc5bb179921864
Autor:
Biagio Paolini, Valentina Chiappa, Monika Ducceschi, Mara Mantiero, Claudia Brusadelli, Giorgio Bogani, Mariateresa Evangelista, Antonino Ditto, Luigi Mariani, Salvatore Lopez, Mauro Signorelli, Fabio Martinelli, Salvatore Lo Vullo, Francesco Raspagliesi, Umberto Maggiore
Publikováno v:
European Journal of Surgical Oncology. 48:268-274
Objective To evaluate factors impacting survival outcomes in patients with uterine serous carcinoma (USC). Methods Data of consecutive patients diagnosed with USC undergoing surgery between 2000 and 2020 at Fondazione IRCCS Istituto Nazionale Tumori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acda52936d68c61f6be10ca661fee740
https://doi.org/10.1016/j.ejso.2021.10.011
https://doi.org/10.1016/j.ejso.2021.10.011
Autor:
Filippo de Braud, Luigi Mariani, Giancarlo Pruneri, Valentina Guarneri, Enrico Cortesi, Andrea Michelotti, Lucia Del Mastro, Giuseppe Curigliano, Filippo Montemurro, Agnese Losurdo, Daniele Generali, Alessandra Fabi, Rebecca Pedersini, Mariangela Ciccarese, Andrea Rocca, Grazia Arpino, Nicla La Verde, Fabio Puglisi, Lorenzo Gerratana, Salvatore Lo Vullo, Lorenzo Castagnoli, Arta Ajazi, Marika Cinausero, Debora Basile, Anna Moretti, Michela Palleschi, Amelia Vantaggiato, Giovanna Catania, Ottavia Bernocchi, Elisa Agostinetto, Andrea Milani, Dario Trapani, Emanuela Ferraro, Agnese Fabbri, Chiara Molinelli, Claudia De Angelis, Simone Scagnoli, Francesca Ligorio, Carmen G. Rea, Giovanni Randon, Antonio Marra, Gaia Griguolo, Carlo Alberto Giorgi, Luca Moscetti, Luca Lalli, Federico Nichetti, Claudio Vernieri
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2c9b2b078d03a7d71c723d2853b9ca
https://doi.org/10.1158/1078-0432.22479435
https://doi.org/10.1158/1078-0432.22479435
Autor:
Francesca Greco, Carlo Morosi, Anna Maria Frezza, Antonella Brunello, Elena Palassini, Salvatore Lo Vullo, Paolo G. Casali, Luigi Mariani, Silvia Stacchiotti, Bruno Vincenzi, Angelo Paolo Dei Tos, Giacomo Giulio Baldi, Marta Sbaraglia, Gianpaolo Dagrada, Paola Collini, Noemi Simeone
Publikováno v:
Cancer
Background The objective of this study was to report on a retrospective series of patients with epithelioid hemangioendothelioma (EHE) who received treatment with sirolimus within the Italian Rare Cancer Network. Methods From January 2005, 38 adult p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ba770d800a7f254d44f4a53d65d04f
https://doi.org/10.1002/cncr.33247
https://doi.org/10.1002/cncr.33247
Autor:
Michela Casanova, Axel Le Cesne, Olivier Mir, Salvatore Lo Vullo, Jean-Yves Blay, Giovanni Grignani, Maria Abbondanza Pantaleo, A.M. Frezza, Luigi Mariani, Robin L. Jones, Bruno Vincenzi, Alessandro Gronchi, Elena Cojocaru, Angelo Paolo Dei Tos, Mehdi Brahmi, Silvia Stacchiotti, Giacomo Giulio Baldi, Paolo G. Casali, Paola Collini, Carlo Morosi, Tommaso De Pas
Publikováno v:
Oncologist
Background This study aimed to review the activity of cytotoxic chemotherapy in patients with inflammatory myofibroblastic tumors (IMTs) treated at nine European sarcoma reference centers. Materials and Methods Patients of any age, with histologicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd48fc92a2c0dfadd77e4fa45e17c90
https://doi.org/10.1634/theoncologist.2020-0352
https://doi.org/10.1634/theoncologist.2020-0352
Autor:
Noemi Simeone, Marta Sbaraglia, Annarita Palomba, Sandro Pasquali, Filippo Frenos, Dario Callegaro, Luigi Mariani, Giacomo Giulio Baldi, Marta Barisella, Silvia Stacchiotti, Angelo Paolo Dei Tos, Alessandro Gronchi, Marco Gambarotti, Domenico Andrea Campanacci, Anna Maria Frezza, Paolo G. Casali, Salvatore Lo Vullo
Publikováno v:
European Journal of Surgical Oncology. 46:1320-1326
Introduction This case-series is aimed to describe the natural history of epithelioid sarcoma (ES) and to provide insights into the differential clinical behaviour of its two variants (“classic-type” and “proximal-type”). The value of a subty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9592aa2706d971978bd5c50e3d5f8fce
https://doi.org/10.1016/j.ejso.2020.03.215
https://doi.org/10.1016/j.ejso.2020.03.215
Autor:
Roberta Granata, Salvatore Lo Vullo, Carlo Resteghini, Donata Galbiati, Pasquale Quattrone, Salvatore Alfieri, Luigi Mariani, Cristiana Bergamini, Francesca Platini, Susanne Singer, Lisa Licitra, Ester Orlandi, Laura D. Locati, Giuseppina Calareso, Moela Mancinelli, Stefano Cavalieri, Paolo Bossi
Publikováno v:
Cancer. 126:1888-1894
The treatment of patients with recurrent and/or metastatic (R/M) salivary gland adenoid cystic carcinoma (ACC) remains an unmet need.Patients with R/M disease with a history of clinical or symptomatic disease progression within 6 months and a maximum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e27b95f884780981577cdda41fb5d90
https://doi.org/10.1002/cncr.32754
https://doi.org/10.1002/cncr.32754
Autor:
Antoine Italiano, Giovanni Grignani, Luigi Mariani, Paolo G. Casali, Robin L. Jones, Massimiliano Grassi, Akira Kawai, Nicolas Penel, Aurore Vozy, Antonella Brunello, Salvatore Lo Vullo, Paweł Teterycz, Florance Duffaud, Tom Wei-Wu Chen, Francesco Tolomeo, Robert S. Benjamin, Giacomo Giulio Baldi, Andrzej Tysarowski, Bruno Vincenzi, Shintaro Iwata, Alannah Smrke, Nadia Hindi, Hans Gelderblom, Winette T. A. van der Graaf, Anna Maria Frezza, Elizabeth Connolly, Javier‐Martin Broto, Silvia Stacchiotti, Vinod Ravi, Alexander Fedenko
Publikováno v:
Cancer Medicine, 10(8), 2645-2659. WILEY
Cancer Medicine, 10, 8, pp. 2645-2659
Cancer Medicine
Cancer Medicine, 10, 2645-2659
Cancer Medicine, Vol 10, Iss 8, Pp 2645-2659 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Medicine, 10, 8, pp. 2645-2659
Cancer Medicine
Cancer Medicine, 10, 2645-2659
Cancer Medicine, Vol 10, Iss 8, Pp 2645-2659 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Background] This observational, retrospective effort across Europe, US, Australia, and Asia aimed to assess the activity of systemic therapies in EHE, an ultra-rare sarcoma, marked by WWTR1-CAMTA1 or YAP1-TFE3 fusions.
[Methods] Twenty sarcoma
[Methods] Twenty sarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26593386408c206f394c8abf875a51c5
https://hdl.handle.net/1887/3276579
https://hdl.handle.net/1887/3276579
Autor:
Giovanna Catania, Fabio Puglisi, Dario Trapani, Federico Nichetti, Lorenzo Gerratana, Alessandra Fabi, Marika Cinausero, Michela Palleschi, Agnese Losurdo, Filippo Montemurro, Enrico Cortesi, Rebecca Pedersini, Andrea Rocca, Carlo Alberto Giorgi, Grazia Arpino, Gaia Griguolo, Lorenzo Castagnoli, Giancarlo Pruneri, Andrea Michelotti, Giuseppe Curigliano, Valentina Guarneri, Francesca Ligorio, Giovanni Randon, Daniele Generali, Emanuela Ferraro, Luca Moscetti, A. Fabbri, Arta Ajazi, Elisa Agostinetto, Claudia De Angelis, Amelia Vantaggiato, Carmen G. Rea, Antonio Marra, Filippo de Braud, Nicla La Verde, Debora Basile, Lucia Del Mastro, Luigi Mariani, Salvatore Lo Vullo, Mariangela Ciccarese, Anna Moretti, Simone Scagnoli, Claudio Vernieri, Ottavia Bernocchi, Chiara Molinelli, Andrea Milani, Luca Lalli
Purpose: The mTOR complex C1 (mTORC1) inhibitor everolimus in combination with the aromatase inhibitor exemestane is an effective treatment for patients with hormone receptor—positive (HR+), HER2-negative (HER2−), advanced breast cancer (HR+/HER2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c55553685783be74ffe3ea6e753cdb9
https://hdl.handle.net/11573/1676736
https://hdl.handle.net/11573/1676736
Autor:
Alexandra Meurgey, Paolo G. Casali, Katherine Thornton, Scott M. Schuetze, Maria Abbondanza Pantaleo, Jean-Yves Blay, Marta Sbaraglia, Salvatore Lo Vullo, Tarek Assi, Paweł Teterycz, Robert G. Maki, Hans Gelderblom, Anna Maria Frezza, Robin L. Jones, Jason L. Hornick, Olivier Mir, Eytan Ben-Ami, Silvia Stacchiotti, Axel Le Cesne, Vinod Ravi, Luigi Mariani, Ingrid M.E. Desar, Alexander Fedenko, Anna M. Czarnecka, Florence Duffaud, Andrew J. Wagner, Richard Ferraro, Akira Kawai, Emi Noguchi, Brittany Siontis, Robert S. Benjamin, Bruno Vincenzi, Alessandro Gronchi, Giacomo Giulio Baldi, Mrinal M. Gounder, Armelle Dufresne, Julien Adam, Kan Yonemori, Marta Barisella
Publikováno v:
Cancer, 126, 1, pp. 98-104
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Contains fulltext : 220839.pdf (Publisher’s version ) (Closed access) BACKGROUND: Intimal sarcoma (InS) is an exceedingly rare neoplasm with an unfavorable prognosis, for which new potentially active treatments are under development. We report on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be658f0d6087906fb37344e619ca0e8
https://hdl.handle.net/2066/220839
https://hdl.handle.net/2066/220839